Changes of bone resorption marker (NTX) in chemotherapy plus zoledronic acid versus chemotherapy alone for nasopharyngeal cancer patients with bone metastases-Reference-Cited by-同舟云学术

Changes of bone resorption marker (NTX) in chemotherapy plus zoledronic acid versus chemotherapy alone for nasopharyngeal cancer patients with bone metastases

Published:2011-04 Issue:6 Volume:47 Page:848-853
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Zhao Yuan-Yuan,Xue Cong,Hou Xue,Liao Hai,Li Su,Zhao Hong-Yun,Huang Yan,Chen Li-Kun,Xu Fei,Liu Jun-Ling,Zhang Li

Funder

National High Technology Research and Development Program of China

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference20 articles.

1. Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments;Tao;Expert Rev Mol Med,2007

2. Patterns of distant metastases in nasopharyngeal carcinoma;Huang;Kaohsiung J Med Sci,1996

3. Distant metastases from nasopharyngeal cancer;Chiesa;ORL J Otorhinolaryngol Relat Spec,2001

4. Carcinoma of the nasopharynx. An analysis of 91 cases and a comparison of differing treatment approaches;Rahima;Cancer,1986

5. Bisphosphonates in breast cancer;Coleman;Ann Oncol,2005

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Antiresorptive Drugs on Bone Mineral Density in Post-Menopausal Women With Early Breast Cancer Receiving Adjuvant Aromatase Inhibitors: A Systematic Review of Randomized Controlled Trials;Frontiers in Oncology;2022-01-21

2. Bone remodeling markers and bone cancer;Bone Cancer;2022

3. What is the relationship between bone turnover markers and skeletal-related events in patients with bone metastases from solid tumors and in patients with multiple myeloma? A systematic review and meta-regression analysis;Bone Reports;2020-06

4. Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials;Pharmacology & Therapeutics;2016-02

5. Bone remodeling markers and bone cancer;Bone Cancer;2015